Silence Therapeutics plc

Silence Therapeutics plcverified

SLN

Price:

$18.31

Market Cap:

$645.02M

Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated genes in the liver. It designs short interfering RNA molecules to harness the body's natural mechanism of RNA interference, and degrading messenger RNA molecules that encode specific targeted disease-associated proteins in a cell. The company is developing various product candidates, including SLN360, which is Phase I clinical trials for the treatmen...[Read more]

Industry

Biotechnology

IPO Date

2020-09-08

Stock Exchange

NASDAQ

Ticker

SLN

The Dividend Yield as of September 2024 (TTM) for Silence Therapeutics plc (SLN) is 0%

According to Silence Therapeutics plc’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Silence Therapeutics plc (SLN) Historical Dividend Yield (quarterly & annually)

How has SLN Dividend Yield performed in the past?

The mean historical Dividend Yield of Silence Therapeutics plc over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), SLN's Dividend Yield was at its highest in in the September 2014 quarter at 0%. The Dividend Yield was at its lowest in in the September 2014 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Silence Therapeutics plc (SLN) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Silence Therapeutics plc Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%
20140%0%

Silence Therapeutics plc (SLN) Average Dividend Yield

How has SLN Dividend Yield performed in the past?

The current Dividend Yield of Silence Therapeutics plc (SLN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Silence Therapeutics plc (SLN) Dividend Yield vs. Peers

How is SLN’s Dividend Yield compared to its peers?

Silence Therapeutics plc’s Dividend Yield is less than Cidara Therapeutics, Inc. (0%), less than Applied Therapeutics, Inc. (0%), less than CytomX Therapeutics, Inc. (0%), less than Shattuck Labs, Inc. (0%), less than C4 Therapeutics, Inc. (0%), less than Eliem Therapeutics, Inc. (0%), less than Prelude Therapeutics Incorporated (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Opthea Limited (0%), less than Centessa Pharmaceuticals plc (0%), less than Nuvalent, Inc. (0%), less than Tarsus Pharmaceuticals, Inc. (0%), less than Genfit S.A. (0%), less than Avidity Biosciences, Inc. (0%), less than IGM Biosciences, Inc. (0%), less than Cerevel Therapeutics Holdings, Inc. (0%), less than Cullinan Oncology, Inc. (0%), less than Mineralys Therapeutics, Inc. (0%), less than null (0%),

Build a custom stock screener for Silence Therapeutics plc (SLN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Silence Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Silence Therapeutics plc (SLN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Silence Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Silence Therapeutics plc's Dividend Yield?

How is the Dividend Yield calculated for Silence Therapeutics plc (SLN)?

What is the highest Dividend Yield for Silence Therapeutics plc (SLN)?

What is the 3-year average Dividend Yield for Silence Therapeutics plc (SLN)?

What is the 5-year average Dividend Yield for Silence Therapeutics plc (SLN)?

How does the current Dividend Yield for Silence Therapeutics plc (SLN) compare to its historical average?